<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0036">
 <label>36</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Chohan</surname>
    <given-names>TA</given-names>
   </name>, 
   <name name-style="western">
    <surname>Qian</surname>
    <given-names>H</given-names>
   </name>, 
   <name name-style="western">
    <surname>Pan</surname>
    <given-names>Y</given-names>
   </name>, 
   <name name-style="western">
    <surname>Chen</surname>
    <given-names>JZ.</given-names>
   </name>
  </person-group>
  <article-title>Cyclin-dependent kinase-2 as a target for cancer therapy: progress in the development of CDK2 inhibitors as anti-cancer agents</article-title>. 
  <source>Curr Med Chem</source>
  <year>2015</year>;
  <volume>22</volume>:
  <fpage>237</fpage>â€“
  <lpage>63</lpage>.
  <pub-id pub-id-type="pmid">25386824</pub-id>
 </mixed-citation>
</ref>
